Engineered Probiotics Offer Oral, Glucose-Responsive Diabetes Therapy in Animal Models
Researchers have developed a glucose-sensing probiotic that can lower blood sugar in mice and monkeys without requiring cell transplantation. The engineered bacteria detect high glucose levels in the gut and release therapeutic agents to manage diabetes, showing promise for treating complications and improving lipid profiles.